Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Radiopharmaceuticals Market In 2029?

The steady expansion of the radiopharmaceuticals market has been noted in the past few years, with predictions estimating a rise from $6.46 billion in 2024 to $6.77 billion in 2025, constituting a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth throughout the historic period include increased healthcare spending, governmental actions, the convenience provided by the treatment, and shifts in lifestyle patterns.

What Growth Rate Is Forecasted for the Radiopharmaceuticals Market by 2029?

Growth is predicted to surge in the radiopharmaceuticals market, projecting it to reach a market value of $10.59 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this expected growth in the forecast period includes a rising elderly population, heightened incidences of cancer and cardiovascular diseases, substantial capital investments, and innovative product introductions. Forecast period trends encompass collaborations with other corporations for revenue enhancement and product quality improvement, investing in expanding plant capacities to fulfill increasing demand, incorporation of new technologies to service emerging needs, the utilization of in silico modelling for a logical and scientific method, investing in AI to decrease R&D expenses and expedite drug development, investing in cardiology-focused technologies to increase revenues, and adopting disease-specific methodologies for precise and timely cancer diagnoses.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp

Which Key Companies Are Shaping the Future of the Radiopharmaceuticals Market?

Major companies operating in the radiopharmaceuticals market include Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, ÚJV Řež, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacýbaþý-Monrol Nuclear Products, NTP Radioisotopes.

Which Factors Are Driving Demand in the Radiopharmaceuticals Industry?

The growing incidence of cancer and cardiovascular problems is anticipated to fuel the need for radiopharmaceuticals in the healthcare market. Instead of conventional medications, radiopharmaceuticals are fast becoming a viable and safe method of treatment. They have distinct advantages such as targeted therapy which makes them a preferable choice for radiologists to treat cancer and cardiovascular illnesses. Globally, cancer is recognized as the second leading cause of fatalities, with 1 in 6 deaths ascribed to it. For instance, the France-based International Agency for Research on Cancer (IARC) reported in April 2024 that nearly 20 million novel cancer cases and 9.7 million cancer-related deaths happened across the globe in 2022. By 2040, these figures are expected to rise to 29.9 million new occurrences and 15.3 million deaths on a yearly basis. Therefore, the increasing instances of cancer and cardiovascular conditions are believed to augment the demand for radiopharmaceuticals in treating these ailments.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3471&type=smp

How Is the Radiopharmaceuticals Market Segmented by Several Divisions?

The radiopharmaceuticals market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications

3) By End User: Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes

Subsegments:

1) By Diagnostic: Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals

2) By Therapeutic: Alpha Emitters, Beta Emitters, Brachytherapy

What are the Emerging Market Trends Driving the Growth of the Radiopharmaceuticals Industry?

Numerous businesses are adopting a variety of strategic maneuvers like launching new manufacturing sites and boosting factory capabilities. This trend is gaining considerable traction in the radiopharmaceuticals market. For example, ITM Isotopen Technologien Munchen AG (ITM), has declared the inauguration of its newest production facility in the Munich vicinity, aiming to amplify the production volume of high-purity (n.c.a) Lutetium-177 and no-carrier-added (n.c.a) Lutetium-177 inclusive radiopharmaceuticals. The brand EndolucinBeta markets the well-known Lutetium-177, an innovative isotope applied in cancer treatment. With this move, the company aims to cater to the escalating global demand for superior quality medical isotopes in the field of precision oncology.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Which Regions Are Driving Growth in the Radiopharmaceuticals Market?

The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3471

This Report Delivers Insight On:

1. How big is the radiopharmaceuticals market, and how is it changing globally?

2. Who are the major companies in the radiopharmaceuticals market, and how are they performing?

3. What are the key opportunities and risks in the radiopharmaceuticals market right now?

4. Which products or customer segments are growing the most in the radiopharmaceuticals market?

5. What factors are helping or slowing down the growth of the radiopharmaceuticals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model